40 Chapter 2 References 1. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007;196(2):147-8. 2. Leppanen M, Lapinleimu H, Lind A, Matomaki J, Lehtonen L, Haataja L, et al. Antenatal and postnatal growth and 5-year cognitive outcome in very preterm infants. Pediatrics. 2014;133(1):63-70. 3. Johnson S, Fawke J, Hennessy E, Rowell V, Thomas S, Wolke D, et al. Neurodevelopmental disability through 11 years of age in children born before 26 weeks of gestation. Pediatrics. 2009;124(2):e249-e57. 4. Cooke RW, Foulder-Hughes L. Growth impairment in the very preterm and cognitive and motor performance at 7 years. Arch Dis Child. 2003;88(6):482-7. 5. Franz AR, Pohlandt F, Bode H, MihatschWA, Sander S, KronM, et al. Intrauterine, early neonatal, and postdischarge growth and neurodevelopmental outcome at 5.4 years in extremely preterm infants after intensive neonatal nutritional support. Pediatrics. 2009;123(1):e101-e9. 6. Ehrenkranz RA, Dusick AM, Vohr BR, Wright LL, Wrage LA, Poole WK. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics. 2006;117(4):1253-61. 7. Rotteveel J, van Weissenbruch MM, Twisk JW, HA D-VdW. Infant and childhood growth patterns, insulin sensitivity, and blood pressure in prematurely born young adults. Pediatrics. 2008;122(2):313-21. 8. Kerkhof GF, Breukhoven PE, Leunissen RW, Willemsen RH, Hokken-Koelega AC. Does preterm birth influence cardiovascular risk in early adulthood? J Pediatr. 2012;161(3):390-6. 9. Stigson L, Kistner A, Sigurdsson J, Engstrom E, Magnusson P, Hellstrom A, et al. Bone and fat mass in relation to postnatal levels of insulin-like growth factors in prematurely born children at 4 y of age. Pediatr Res. 2014;75(4):544-50. 10. Lafeber HN, van de Lagemaat M, Rotteveel J, van Weissenbruch M. Timing of nutritional interventions in very-low-birth-weight infants: optimal neurodevelopment compared with the onset of the metabolic syndrome. Am J Clin Nutr. 2013;98(2):556S-60S. 11. Rigo J, Senterre T. Intrauterine-like growth rates can be achieved with premixed parenteral nutrition solution in preterm infants. J Nutr. 2013;143(12 Suppl):2066S-70S. 12. DR C. Physiology of insuline-like growth factor I. http://www uptodate com/contents/ physiology-of-insulin-like-growth-factor-i [Internet]. 2014 2/5/2014. Available from: http://www. uptodate.com/contents/physiology-of-insulin-like-growth-factor-i. 13. Hawkes CP, Grimberg A. Measuring growth hormone and insulin-like growth factor-I in infants: what is normal? Pediatr Endocrinol Rev. 2013;11(2):126-46. 14. Hansen-Pupp I, Lofqvist C, Polberger S, Niklasson A, Fellman V, Hellstrom A, et al. Influence of insulin-like growth factor I and nutrition during phases of postnatal growth in very preterm infants. Pediatr Res. 2011;69(5 Pt 1):448-53. 15. Kurtoglu S, Kondolot M, Mazicioglu MM, Hatipoglu N, Akin MA, Akyildiz B. Growth hormone, insulin like growth factor-1, and insulin-like growth factor-binding protein-3 levels in the neonatal period: a preliminary study. J Pediatr Endocrinol Metab. 2010;23(9):885-9. 16. Martos-Moreno GA, Barrios V, Saenz de PM, Pozo J, Dorronsoro I, Martinez-Biarge M, et al. Influence of prematurity and growth restriction on the adipokine profile, IGF1, and ghrelin levels in cord blood: relationship with glucose metabolism. Eur J Endocrinol. 2009;161(3):381-9. 17. Ohkawa N, Shoji H, Kitamura T, Suganuma H, Yoshikawa N, Suzuki M, et al. IGF-I, leptin and active ghrelin levels in very low birth weight infants during the first 8 weeks of life. Acta Paediatr. 2010;99(1):37-41. 18. van de Lagemaat M, Rotteveel J, Heijboer AC, Lafeber HN, van Weissenbruch MM. Growth in preterm infants until six months postterm: the role of insulin and IGF-I. Horm Res Paediatr. 2013;80(2):92-9.
RkJQdWJsaXNoZXIy MTk4NDMw